Skip to content
QuantCalc Tools

Institution record

FXGM

Depaho Ltd

Risk level not supplied2 of 2 licences marked regulated
Source score
—
Warnings
0
Comments
0

Licence records

Licences within our coverage (firms authorised in the uk, ireland and gibraltar) are listed first. Check each one on the regulator's own register.

RegulatorLicence no.StatusLicensed entityDate
CYSECTier-2
Cyprus Securities and Exchange Commission
161/11RegulatedNaxex Invest Ltd2011-12-27
FSCATier-2
Financial Sector Conduct Authority
47709RegulatedNAXEX INVEST LTD2017-04-04

Peer regulatory & risk comparison

Side-by-side supervisory and risk benchmark comparing FXGM against peer institutions in our firms authorised in the uk, ireland and gibraltar dataset.

Full directory →
InstitutionPrimary regulatorsRegulated / totalRisk classificationSource scoreWarnings
FXGM (this record)
CYSECFSCA
2 / 2Risk level not supplied—0
Finalto
FCAFCAASIC+1
4 / 4Risk level not supplied—0
AvaTrade
CBIFSAFSCA+5
8 / 8Risk level not supplied—0
FxPro
FCABaFinFSCA+3
4 / 6Risk level not supplied—0
GLOBAL
FCACYSECVFSC+3
5 / 6Risk level not supplied—0
Pepperstone
FCACYSECBaFin+3
4 / 6Risk level not supplied—0

FXGM: institutional due diligence FAQ

Key supervisory, licensing, and counterparty verification questions generated from the dataset.

What is FXGM's regulatory licence status and supervisory authorisation?

In our imported dataset, FXGM (legal entity reference: Depaho Ltd) holds 2 recorded licence entries, of which 2 carry a "regulated" status and 2 are marked regulated or registered: CYSEC (Cyprus Securities and Exchange Commission) — licence 161/11, status: regulated, Tier-2; FSCA (Financial Sector Conduct Authority) — licence 47709, status: regulated, Tier-2. Institutional due diligence requires verifying that the exact legal entity on your counterparty agreement matches the licensed entity name and registration number on the official CYSEC, FSCA public register.

Which of FXGM's jurisdictions and licences fall within this site's regulatory coverage?

FXGM is registered at Artemisia Business Centre, 14 Charalambou Mouskou, 2nd Floor, Office 201, 2014 Nicosia, Cyprus. and tracked under our firms authorised in the uk, ireland and gibraltar scope based on its institutional service profile (Derivatives contracts, Forex, Stocks, Commodities) rather than a domestic focus licence. Its 2 recorded licences (CYSEC, FSCA) should be evaluated for cross-border passporting and local solicitation rules.

What is FXGM's institutional risk classification, enforcement exposure, and score profile?

FXGM carries a "risk level not supplied" classification in the source dataset (composite numeric scores are not supplied for this record). The record flags 0 regulatory warning or complaint counts. Because these figures reflect imported source fields rather than primary audit findings, compliance teams should review primary enforcement bulletins directly.

What operational due diligence steps apply to FXGM's platforms, entity structure, and complaints?

Before allocating capital or executing trades with FXGM, institutional and retail allocators should: (1) confirm the domain (fxgm.com) against regulator-approved domains to guard against clone firms; (2) verify whether any of the 0 recorded warning/complaint entries or 0 user comments involve withdrawal restrictions or scope violations; and (3) confirm the dispute-resolution ombudsman tied to CYSEC.

Editorial briefings and compliance research from QuantCalc Tools relevant to FXGM's supervisory scope.

All research →

Quantitative Risk & Capital Modeling

Basel III Endgame FRTB & ISDA SIMM v2.6+ Quantitative Calibration: Expected Shortfall, Non-Modellable Risk Factors (NMRF), and Cross-Margin Capital Optimization (2026)

Complete quantitative specification of BCBS MAR20-MAR33 Fundamental Review of the Trading Book (FRTB), 97.5% Expected Shortfall liquidity horizon scaling, Risk Factor Eligibility Tests (RFET), SA-CCR alpha factors, and ISDA SIMM initial margin optimization.

Read briefing →

Quantitative Execution & Fee Math

CME SPAN 2 Historical VaR Margin Methodology, Cross-Margining Haircuts & Portfolio Kelly Criterion Optimization

CME SPAN 2 Historical Value-at-Risk (HVaR) margin methodology refers to an institutional clearing risk framework that replaces legacy 16-scenario parametric grid arrays with a 99.0% confidence Filtered Historical Simulation (FHS) engine incorporating exponentially weighted volatility scaling and stress-period tail scenarios. Across multi-asset fixed-income and equity index derivatives portfolios, integrating CME–FICC cross-margining offsets with variance-penalized multi-asset Kelly Criterion sizing reduces initial margin encumbrance by up to 75.0% [75.0%, CME Group Clearing & FICC Cross-Margining Benchmark, Q1 2026] while compressing annualized collateral drag by 142 bps [142 bps, Federal Reserve Bank of New York Reference Rate & Treasury Repo Study, February 2026].

Read briefing →

Fixed Income Duration & Portfolio Risk

Compounded SOFR In-Arrears, NY Fed SOFR Index & Repo Carry Trade Calculator Guide

Exact ACT/360 mathematical specification for New York Fed Compounded SOFR in-arrears, SOFR Index ratio pricing, 5-day lookback observation shifts, and leveraged U.S. Treasury repo carry trade breakeven calculations.

Read briefing →

Quantitative Pricing & Options Engines

NY Fed SOFR Index ACT/360 In-Arrears Compounding Engine: Closed-Form Mathematical Specification & IEEE-754 Verification (4.4151% 90-Day Annualized Benchmark)

NY Fed SOFR Index ACT/360 In-Arrears Compounding Engine (SOFR-INDEX-ACT360) stands at 4.4151% (90-Day Annualized) (Source: NY Fed Reference Rates, 2026-10-20), governing exact floating-point precision, day-count conventi

Read briefing →
FXGM — Regulation, Licence Records & Risk Profile | QuantCalc Tools